Nanovia | Targeted Nanomedicine Platform

A new architecture for targeted cancer therapy.

A next-generation platform designed to combine tumor-targeting antibodies with albumin nanoparticles and high-capacity therapeutic payloads.

A concise view of the platform, evidence, and development path.

How the modular nanoparticle architecture works.

Selected clinical, regulatory, and scientific signals.

Lead program, follow-on pipeline, and next milestones.

Peer-reviewed publications, abstracts, and scientific presentations.

A modular platform for targeted drug delivery.